This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Reawakening Australia: The economic cost of sleep disorders in Australia

New sleep disorders research quantifies health care and indirect costs


DOWNLOAD  

Reawakening Australia: The economic cost of sleep disorders in AustraliaMore than 1.5 million Australian adults - 9% of the adult population - suffer from sleep disorders, including obstructive sleep apnoea, insomnia and restless leg syndrome. In total, sleep disorders cost the Australian economy more than $5.1 billion a year in health care and indirect costs.

Of the more than $800 million of direct health system costs annually, $270 million is spent caring for sleep disorders with another $540 million spent in health care costs for associated conditions. Of the $4.3 billion per year of indirect costs, $3.1 billion relate to lost productivity with a further $650 million related  to informal care and other indirect costs associated with motor vehicle and workplace accidents.

This report by Deloitte Access Economics, undertaken for the Sleep Health Foundation - a not-for-profit organisation set up to raise awareness of the issues associated with sleep disorders - also quantifies the contribution of sleep disorders to other diseases and injuries including depression, stroke, workplace injuries and motor accidents.  

The report is structured as follows:

Executive summary
Section 1: Sleep disorders in Australia – prevalence, in children, relation to other health conditions and risk of  accidents
Section 2: Population attributable factors – methodology, cardiovascular disease, depression, injuries
Section 3: Health costs of sleep disorders
Section 4 Indirect costs – productivity, informal care, other costs of motor vehicle accidents, workplace accidents, deadweight loss
Section 5: Burden of disease – methodology, disability weights, loss in the stock of health capital
Section 6: Cost effectiveness of CPAP – description, safety and efficacy of CPAP therapy
Section 7: Comparisons and opportunities
References

Related links

Share

 
Follow us



 

Talk to us